Dermatology CME Courses

The Dermatology Board Review presents an educationally beneficial review of Dermatology and intense regimen that will prepare attendees for the Dermatology Board exam, maintenance of certification self-assessment questions, and recertifying exam. This course is intended to be a comprehensive review of probable topics that could appear on the exam. The course will focus on general dermatology subjects such as basic science, basement membrane biology, dermatological manifest of internal disease, hair and nail biology/disorders, skin cancer, pediatric dermatology, drug metabolism, and many more. Sections will be commited to reviewing both exam relevant procedural dermatology and dermatopathology.

After completely viewing each lecture, attendees will be required to finish a five to 10 question quiz. Quiz questions will be multiple-choice or true-false and will include pictures derived from the PowerPoint presentation that are a part of the presentation. Once the participant passes the quiz by correctly answering 60% or more of the questions, the lecture is successfully completed. Upon conslusion of the lecture and passing the correlating quiz, learners will be given the opportunity to submit for continuing education credit.

Participants will also be given surveys as a form of course evaluation in order to further evaluate any missing needs and continually improve this ongoing academic program.

Board Vitals offers hundreds of Dermatology Questions targeted to the ABDERM and MOC:PQRS exam. Our question bank is specifically designed around difficult questions, with detailed explanations around the correct answer.

The logistics – the Derm exam is a long exam (8 hours) and has a fairly middle of the road pass rate compared to the other specialties. (90% pass rate average over the past several years) There are two major sections – the Dermatopathology and Virtual Dermatopathology Section, and the written Multiple Choice Section (300 Questions).

The vast majority of students that score at least 60% correct on our Dermatology practice questions pass the board exam. It is very rare for someone to exceed the average - 62% threshold on our exam - and not pass the boards. When using our question bank, a primary goal should be focusing on not performing in the lowest 20% of test takers. (Each question comes with an individual average score)<

This CME program offers a broader approach to treating patients with dermatology needs on an ongoing basis, stressing practical problem-solving and disease management. Focused on total patient care — from diagnosis of common skin conditions and lesions, to developing a treatment plan and establishing skin care management — Dermatology for Primary Care faculty will:

• Define fundamentals of the dermatologic exam, using real-patient photography to illustrate skin conditions from common acne and eczema to melanoma and other skin cancers
• Pull from real-patient examples to demonstrate common patterns of presentation
• Discuss how to approach patients who don’t improve and what adjustments to make when conditions change

Directed by Dirk Elston, MD, FAAD, Masters of Pathology Series – Dermatopathology highlights recent updates and emerging knowledge affecting this advanced subspecialty. Dr. Elston is joined by a distinguished faculty from leading institutions to cover pressing topics such as genodermatoses, lymphomas, unusual skin infections, vascular tumors, and more.By completing this CME program, you'll improve your ability to:Effectively use clinicopathologic correlations to diagnose inflammatory skin diseases and alopeciaApply immunohistochemical tools to diagnose melanocytic lesions and lymphoid infiltratesUse precise, uniform terminology in the diagnosis of melanocytic lesions

By the end of the session the participant will be able to:

• Describe the role of the immune system in cancer and cancer therapy in metastatic melanoma.
• Distinguish between the different forms of therapy presently approved for metastatic melanoma and apply them to practice, taking into account the following: treatment modalities and the recent clinical trial evidence supporting them.
• Describe emerging (investigational) therapies for metastatic melanoma
• Describe the challenges and barriers to care associated with treating patients with metastatic melanoma

Learning Objectives:

• Summarize the most impactful findings presented at ASCO 2017 relating to Metastatic Melanoma and apply them to patient cases, taking into account any relevant barriers to care.
• Additional objectives to be dictated by clinical content

Get Connected Online

Practical Reviews is just that—practical, expert reviews of the most relevant articles from leading medical journals in Dermatology.

Connect to Research Summaries from Leading Medical Journals

Our expert medical faculty conduct a comprehensive review of hundreds of articles from current leading medical journals so you don’t have to. Our knowledge leaders summarize the most relevant medical research for you to review at your convenience and add commentary with perspective for applying these findings in your own practice.

Connect to Practical Reviews in Dermatology and get:

• 16 articles summarized in each issue, each with an expert audio review
• Online quizzes and instant pass/fail notification
• Instant access to our database of Dermatology journal reviews
• 14 issues annually
• Ability to earn up to 56 AMA PRA Category 1 Credits ™

Plus you'll have access to the Best of Practical Reviews, Volume 1. This expertly curated compilation of the year's 800+ key audio commentaries and written summaries focuses on the hottest topics, newest technologies, groundbreaking clinical tests, and more.

By the end of the session the participant will be able to:

• Describe the role of the immune system in cancer and cancer therapy in metastatic melanoma.
• Distinguish between the different forms of therapy presently approved for metastatic melanoma and apply them to practice, taking into account the following: treatment modalities and the recent clinical trial evidence supporting them.
• Describe emerging (investigational) therapies for metastatic melanoma
• Describe the challenges and barriers to care associated with treating patients with metastatic melanoma